
© Sputnik/Ilya Pitalev
Russian intensive care unit at work
A group of Russian scientists have created a drug that may potentially revolutionize the treatment of Covid-19 by defusing the most catastrophic reaction the disease causes in patients, while not destroying their immune response.
The drug, called
Leitragin, was developed by the
Biomedical Technology Research Center of the Russian Federal Medical and Biology Agency (FMBA), and is currently undergoing clinical trials in Russia. Although its base substance was previously known and used in ulcer treatment medicine by Soviet and Russian doctors, it was the FMBA team that discovered how to apply it for the treatment of severe cases of Covid-19 and, potentially, other deadly diseases that cause life-threatening lung inflammation.
The Russian scientists had tasked themselves with finding
a substance that would act as an 'off switch' for the chain reaction that, after being triggered by the invading SARS-CoV-2 virus, actually causes potential organ failure and death. This reaction of the immune system, dubbed the
"cytokine storm," has been variously
described as our
body's overreaction to the virus or a "suicide attack" against the invading pathogen, and even as an evolutionary mechanism to stop the spread of deadly infections with the death of the host.
Trying to stop this uncontrolled immune response while still preserving the body's ability to fight the virus without causing more damage is what scientists and medics in intensive care units across the world have been wrestling with during the Covid-19 pandemic. In that regard,
Leitragin is being touted as a game-changer, since its novel mechanism acts in a targeted way, and is said to be completely safe for one's health.
RT interviewed the head of the Russian team of scientists behind Leitragin, and talked to an independent researcher studying cytokine storms, to learn more about the potential of the novel drug.
Comment: Clube's and Napier's hypothesis is being borne out by the worrying increase in fireball counts year-over-year. SOTT's Fire in the Sky section attests to that.